- Session 1: COVID 19 vaccine impact modelling
- Session 2: Dengue disease impact and cost-effectiveness: Optimizing public health impact
- Session 3: Dengue disease impact and cost-effectiveness: Benefit-risk assessments
- Session 4: MNTE validation methods for assessments in conflict areas
- Session 5: Estimating the value of vaccines in preventing antimicrobial resistance
- Session 6: Vaccine impact modelling (IA2030 and VIMC)
- Session 7: Typhoid Conjugate Vaccine Micro Array Patches (TCV-MAP) FVVA
Meeting materials